- Home
- DEA vs CBLL Comparison
DEA vs CBLL Comparison
Compare DEA & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DEA | CBLL |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 935.3M |
| IPO Year | 2014 | 2024 |
Fundamental Metrics
Financial Performance| Metric | DEA | CBLL |
|---|---|---|
| Price | $21.81 | $25.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $25.36 | ★ $28.57 |
| AVG Volume (30 Days) | ★ 509.2K | 384.8K |
| Earning Date | 10-26-2026 | 11-03-2026 |
| Dividend Yield | ★ 8.19% | N/A |
| EPS Growth | 50.00 | ★ 56.93 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $336,099,000.00 | $89,063,000.00 |
| Revenue This Year | $7.51 | $29.66 |
| Revenue Next Year | $2.57 | $27.36 |
| P/E Ratio | $274.88 | ★ N/A |
| Revenue Growth | 11.27 | ★ 36.09 |
| 52 Week Low | $20.56 | $10.85 |
| 52 Week High | $25.96 | $27.94 |
Technical Indicators
Market Signals| Indicator | DEA | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 27.90 | 55.82 |
| Support Level | $21.65 | $22.64 |
| Resistance Level | $23.74 | N/A |
| Average True Range (ATR) | 0.48 | 1.29 |
| MACD | -0.08 | 0.22 |
| Stochastic Oscillator | 4.79 | 56.95 |
Price Performance
Historical ComparisonAbout DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.
About CBLL CeriBell Inc.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.